CENTRUM MEDYCZNE LUCYNA ANDRZEJ DYMEK
- Address
- lock Available on a paid plan
CENTRUM MEDYCZNE LUCYNA ANDRZEJ DYMEK - Respiratory Research Center
CENTRUM MEDYCZNE LUCYNA ANDRZEJ DYMEK is a clinical research facility specializing in respiratory medicine with a focus on advanced therapeutic interventions for chronic lung diseases. The center demonstrates particular expertise in conducting complex comparative efficacy studies evaluating novel pharmacological combinations for pulmonary conditions.
- Chronic Obstructive Pulmonary Disease (COPD) clinical trials
- Fixed-dose combination therapy evaluations
- Pulmonary function testing and lung function assessments
The center's research portfolio includes sophisticated studies examining triple versus dual combination therapies in COPD management, with emphasis on measuring objective outcomes such as forced expiratory volume (FEV1) and comprehensive safety and tolerability profiles. This work contributes to advancing treatment options for patients with chronic respiratory diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Kymera Therapeutics Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CENTRUM MEDYCZNE LUCYNA ANDRZEJ DYMEK
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Dose-Ranging Study of Oral KT-621 in Adults with Uncontrolled Moderate to Severe Eosinophilic Asthma | Kymera Therapeutics Inc. | Phase II | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Beclometasone Dipropionate Anhydrous | 1 | Unknown | 2022-04-22 | 2022-04-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.